Insider Trading & Ownership of Claude Nicaise

Location: Cambridge, MA
Summary: The estimated net worth of Claude Nicaise is at least $838,124 dollars as of 29 Jan 2026. Claude Nicaise is the Director of Sarepta Therapeutics, Inc. and owns shares of Sarepta Therapeutics, Inc. (SRPT) stock worth about $669.4K. Claude Nicaise is the Director of CASSAVA SCIENCES INC and owns shares of CASSAVA SCIENCES INC (SAVA) stock worth about $168.7K.
Signature: /s/ Cristin L. Rothfuss, as Attorney-in-Fact for Claude Nicaise
All Insider Reports: All Insider Reports

Notify me when Claude Nicaise files a new Insider Trading report.

Ownership of Claude Nicaise

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
SRPT	Sarepta Therapeutics, Inc.	Director	$669,424	-$248,203	-27%	29 Jan 2026
SAVA	CASSAVA SCIENCES INC	Director	$168,700			23 May 2025
CMMB	Chemomab Therapeutics Ltd.	Director				16 Mar 2023
GANX	Gain Therapeutics, Inc.	Director				24 Jun 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.